PT - JOURNAL ARTICLE AU - Oba, Junna AU - Taniguchi, Hiroaki AU - Sato, Masae AU - Takanashi, Masaki AU - Yokemura, Moe AU - Sato, Yasunori AU - Nishihara, Hiroshi TI - SARS-CoV-2 RT-qPCR testing of pooled saliva samples: a case study of 824 asymptomatic individuals and a questionnaire survey in Japan AID - 10.1101/2022.02.02.22269880 DP - 2022 Jan 01 TA - medRxiv PG - 2022.02.02.22269880 4099 - http://medrxiv.org/content/early/2022/02/02/2022.02.02.22269880.short 4100 - http://medrxiv.org/content/early/2022/02/02/2022.02.02.22269880.full AB - From the beginning of the COVID-19 pandemic, the demand for diagnostic and screening tests has exceeded supply. Although the proportion of vaccinated people has increased in wealthier countries, breakthrough infections have occurred amid the emergence of new variants. Pooled-sample COVID-19 testing using saliva has been proposed as an efficient, inexpensive, and non-invasive method to allow larger-scale testing, especially in a screening setting. In this study, we aimed to evaluate pooled RT-qPCR saliva testing and to compare the results with individual tests.Employees of Philips Japan, Ltd. were recruited to participate in COVID-19 screening from October to December 2020. Asymptomatic individuals (n=824) submitted self-collected saliva samples. Samples were tested for the presence of SARS-CoV-2 by RT-qPCR in both 10-sample pools and individual tests. We also surveyed participants regarding their thoughts and behaviors after the PCR screening project.Two of the 824 individuals were positive by RT-qPCR. In the pooled testing, one of these two had no measurable Ct value, but showed an amplification trend at the end of the PCR cycle. Both positive individuals developed cold-like symptoms, but neither required hospitalization. Of the 824 participants, 471 responded to our online questionnaire. Overall, while respondents agreed that PCR screening should be performed regularly, the majority were willing to undergo PCR testing only when it was provided for free or at low cost.In conclusion, pooled testing of saliva samples can support frequent large-scale screening that is rapid, efficient, and inexpensive.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by the Keio University Global Research Institute (KGRI) Research Projects for New Coronavirus Crisis: Implementation of a Keio Model to Optimize SARS-CoV-2 PCR Tests through Systems Approach (PI: Koichi Matsuo), the Japan Agency for Medical Research and Development (AMED) (PI: Hiroshi Nishihara, Grant Number 20he1422004j0001), Grant-in-Aid for Scientific Research (C) of JSPS KAKENHI (PI: Junna Oba, Grant Number JP21K10334), and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) for utilization of the university?s PCR equipment. The funding agencies had no role in the study design, collection, analysis, or interpretation of data in the writing of the report or in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional review board of Keio University (approval number 20200291).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files. https://submit.medrxiv.org/submission/download?msid=MEDRXIV/2022/269880&roleName=author&gotoPageName=proof&continueToPage=proof&supp=true